Question 1

Has Jenny Cure-Twede received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,460 in general payments to Jenny Cure-Twede across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Jenny Cure-Twede did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Jenny Cure-Twede come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
UCB, Inc.	10	$378
AbbVie	10	$158
Eisai Inc.	5	$99
AstraZeneca(2 entities)	3	$81
Biogen	3	$68
Amneal Pharmaceuticals LLC	3	$58
Takeda Pharmaceuticals U.S.A., Inc.	2	$56
Lilly USA, LLC	2	$54
TG Therapeutics, Inc.	2	$52
Argenx US, Inc.	2	$52
Johnson & Johnson(2 entities)	2	$48
Xeris Pharmaceuticals, Inc.	2	$45
Teva Pharmaceuticals USA, Inc.	2	$45
Neurelis, Inc.	2	$42
Merz Pharmaceuticals, LLC	2	$38
C2n Diagnostics, LLC	2	$36
ANI Pharmaceuticals, Inc.	1	$33
Axsome Therapeutics, Inc.	1	$27
Octapharma USA, Inc.	1	$25
EMD Serono, Inc.	1	$22
Pfizer	1	$22
Otsuka America Pharmaceutical, Inc.	1	$21

Jenny Cure-Twede

Payments from drug & device makers

Who reported the general payments

How this compares

Other acute care in Palmetto Bay